‘No more than a drop in the ocean’: this drug could end new HIV infections in Eswatini – why isn’t there enough?

The southern Africa country has the world’s highest prevalence of HIV but the amount of lenacapavir reaching it is too small to reach all those at risk ...
The Observer

The hidden complexities of HIV’s Lenacapavir

Global health is evolving rapidly, with breakthroughs turning into medicine. The latest advancement in viral research is ...
The Miami Times

Intact but not in use: Florida’s AIDS drug formulary advisory panel

The Florida Department of Health limited access to life-saving drugs for people with HIV without consulting its hand-picked ...
Mirage News

HIV Drug Switch Tied to Diabetes Risk: Johns Hopkins Study

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
STATOpinion

Subscription pricing could expand access to HIV prevention breakthrough while controlling costs

Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make ...
BhekisisaOpinion

Here’s how to make drug addiction a health issue, not a criminal one

Experts say South Africa's contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a ...
Orlando Weekly

Florida AIDS drug advisory panel left out of decision to update list of AIDS drugs

DOH Communications Director Brian Wright said the panel remains intact, but some members said they weren't sure it still even ...

$20 Instead Of $14,000: Breakthrough Preventative HIV Drug To Become Affordable In 2027

But there is hope: in September 2025, Unitaid – a global health initiative – announced, in partnership with the Gates Foundation, that it would make this drug available as a generic for around $20 per ...
News24

What breakthrough weight-loss meds might mean for people with HIV

In part 3 of a Spotlight special series on the role of new weight loss medicines like Ozempic in South Africa, we ask what ...

Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
EWN

Health Department urged to ensure accountability in anti-HIV drug rollout

The Forum for South Africa (FOSA) is calling for transparency from the Department of Health in the procurement and roll-out ...
MPR

Switching From HIV Protease Inhibitors to Integrase Strand Transfer Inhibitors Tied to Diabetes Risk

HealthDay News — Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study published online March ...